Deregulating MYC in a model of HER2+ breast cancer mimics human intertumoral heterogeneity
Author:
Funder
National Cancer Institute
U.S. Department of Defense
Publisher
American Society for Clinical Investigation
Subject
General Medicine
Link
https://www.jci.org/articles/view/126390/files/pdf
Reference83 articles.
1. Treatment of HER2-positive breast cancer: current status and future perspectives;Arteaga;Nat Rev Clin Oncol,2011
2. Prognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review
3. Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
4. A single-arm phase II trial of first-line paclitaxel in combination with lapatinib in HER2-overexpressing metastatic breast cancer;Jagiello-Gruszfeld;Oncology,2010
5. Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Reciprocal interactions between lncRNAs and MYC in colorectal cancer: partners in crime;Cell Death & Disease;2024-07-29
2. Bag‐1‐mediated HSF1 phosphorylation regulates expression of heat shock proteins in breast cancer cells;FEBS Open Bio;2024-07-24
3. The Expression of Hsa-Mir-1225-5p Limits the Aggressive Biological Behaviour of Luminal Breast Cancer Cell Lines;MicroRNA;2024-07
4. A comprehensive overview of metaplastic breast cancer: Features and treatments;Cancer Science;2024-05-12
5. MAF1 is a predictive biomarker in HER2 positive breast cancer;PLOS ONE;2023-10-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3